论文信息 - DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma. - 字舞流文

DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma.

B. Jha | Y. Saunthararajah | R. Mahfouz | M. Kalaycio | H. Lazarus | M. Orloff | R. Sobecks | R. Dean | D. Grabowski | F. Reu | E. Malek | Wei Wei | Mohammed S Orloff | C. Samaras | B. Faiman | J. Valent | Kimberly Hamilton | E. Campagnaro | Y. Chew | Sherry Fada | Hien D. Liu | M. Karam | J. Reed | Shahper N. Khan | J. Khouri | S. Khan | S. Khan